Mesa Laboratories, Inc. MLAB
133.41 USD -4.40 (-3.19%)
Regular-session close
133.41 0.00 0.00%
After hours · Nov 19, 4:01 PM ET
132.99 Day range 140.29
70.19 52-week range 144.35
- YTD
- +69.95%
- 1 year
- +88.65%
News
benzinga.com Jefferies Maintains Buy on Mesa Laboratories, Raises Price Target to $150 Jefferies analyst Tycho Peterson maintains Mesa Laboratories (NASDAQ:MLAB) with a Buy and raises the price target from $125 to $150.
seekingalpha.com Mesa Laboratories, Inc. (MLAB) Q2 2027 Earnings Call Transcript Mesa Laboratories, Inc. (MLAB) Q2 2027 Earnings Call Transcript
marketbeat.com What Mesa Laboratories (MLAB) Said on Its Q2 Earnings Call Mesa Laboratories NASDAQ: MLAB reported higher revenue and earnings for its fiscal 2027 second quarter and issued full-year guidance, while outlining plans to restructure its Clinical Genomics…benzinga.com Mesa Laboratories Sees FY2027 Sales $250.000M-$255.000M vs $254.450M Est Mesa Laboratories (NASDAQ:MLAB) sees FY2027 sales of $250.000 million-$255.000 million vs $254.450 million analyst estimate.
benzinga.com Mesa Laboratories Q2 2027 Earnings Call Transcript Mesa Laboratories (NASDAQ:MLAB) reported second-quarter financial results on Monday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is brought…
globenewswire.com Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance LAKEWOOD, Colo., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of critical quality control solutions…
globenewswire.com Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality…
seekingalpha.com Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity Utz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks. Shares of health care management company Astrana Health…
globenewswire.com Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth LAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa,” “we,” “us” or “our”), a global leader in the design and manufacture of critical quality control…
defenseworld.net Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High – Should You Buy? Mesa Laboratories, Inc. (NASDAQ: MLAB - Get Free Report) shares reached a new 52-week high on Monday. The company traded as high as $139.60 and last traded at $140.8960, with a volume of 78444 shares…
gurufocus.com Mesa Laboratories Inc (MLAB) Shares Surge 4.1% -- What GF Score of 75 Tells Investors On September 02, 2026, Mesa Laboratories Inc (MLAB) shares rose 4.1% to $130.65, reflecting a significant increase within a volatile 52-week range of $58.83 to
defenseworld.net Reviewing ImmunoPrecise Antibodies (OTCMKTS:IPATF) & Mesa Laboratories (NASDAQ:MLAB) Mesa Laboratories (NASDAQ: MLAB - Get Free Report) and ImmunoPrecise Antibodies (OTCMKTS:IPATF - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two…
seekingalpha.com Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
marketbeat.com Mesa Laboratories Q1 Earnings Call Highlights Mesa Laboratories NASDAQ: MLAB reported first-quarter fiscal 2027 revenue growth of 1%, improved operating margins and continued debt reduction, while newly appointed President and CEO Siddhartha…
globenewswire.com Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of life science tools…
globenewswire.com MESA LABS DECLARES QUARTERLY DIVIDEND Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular…
fool.com Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today Mesa Laboratories fell after reporting its Q4 fiscal 2026 results. Sales and earnings came in below Wall Street's expected earnings, but the business did report strong growth for adjusted operating…
globenewswire.com Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical…
globenewswire.com Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026 LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31,…
globenewswire.com MESA LABS DECLARES QUARTERLY DIVIDEND LAKEWOOD, Colo. , April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular…
defenseworld.net Mesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened Mesa Laboratories, Inc. (NASDAQ: MLAB - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of…
seekingalpha.com Royce Small-Cap Fund FY 2025: What Worked Five of the Fund's 10 equity sectors made a positive impact on calendar year performance, led by Industrials, Financials, and Information Technology. Alamos Gold's positive earnings outlook, a…
defenseworld.net Principal Financial Group Inc. Decreases Stock Holdings in Mesa Laboratories, Inc. $MLAB Principal Financial Group Inc. lessened its stake in Mesa Laboratories, Inc. (NASDAQ: MLAB) by 66.2% in the undefined quarter, according to the company in its most recent filing with the SEC. The…
